SC
BBNX

Steven Cohen’s Beta Bionics BBNX Stock Holding History

Steven Cohen’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.3M Sell
2,254,683
-270,357
-11% -$3.22M 0.04% 588
2026
Q1 		$25.3M Buy
2,525,040
+1,537,689
+156% +$22.7M 0.03% 684
2025
Q4 		$30.1M Buy
+987,351
New +$26.4M 0.03% 654
2025
Q2 		– Sell
-364,329
Closed -$4.46M – 2676
2025
Q1 		$4.46M Buy
+364,329
New +$6.79M 0.01% 963

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Steven Cohen's BBNX Position: Q2 2026 in Review

Steven Cohen reduced its Beta Bionics (BBNX) stake by 11% in Q2 2026, selling an estimated $3.22M and leaving 2,254,683 shares worth $35.3M. The position accounts for 0.04% of the portfolio, ranked #588.

Steven Cohen first reported a position in BBNX in Q1 2025 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Steven Cohen held 2,254,683 shares of Beta Bionics worth $35.3M as of Q2 2026.
  • Steven Cohen sold 270,357 Beta Bionics shares in Q2 2026, an estimated $3.22M.
  • Beta Bionics made up 0.04% of Steven Cohen's portfolio in Q2 2026, its #588 holding.
  • Steven Cohen first reported a position in Beta Bionics in Q1 2025 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.